MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA WITH BENDAMUSTINE

被引：0
|
作者：
Cerchione, C. [1 ]
Madonna, E. [1 ]
Pareto, A. E. [1 ]
Marano, L. [1 ]
Pugliese, N. [1 ]
Peluso, I. [1 ]
Seneca, E. [1 ]
Cerciello, G. [1 ]
Avilia, S. [1 ]
Basile, S. [1 ]
Pane, F. [1 ]
Catalano, L. [1 ]
机构：
[1] AOU Federico II, Naples, Italy
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1684
引用
收藏
页码：650 / 650
页数：1
相关论文
共 50 条
  • [1] Bendamustine in patients with relapsed or refractory multiple myeloma
    M Michael
    I Bruns
    E Bölke
    F Zohren
    A Czibere
    N N Safaian
    F Neumann
    R Haas
    G Kobbe
    R Fenk
    [J]. European Journal of Medical Research, 15
  • [2] BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Michael, M.
    Bruns, I.
    Boelke, E.
    Zohren, F.
    Czibere, A.
    Safaian, N. N.
    Ncumann, F.
    Haas, R.
    Kobbe, G.
    Fenk, R.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (01) : 13 - 19
  • [3] BENDAMUSTINE-BORTEZOMIB-DESAMETASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Catalano, L.
    Pareto, A. E.
    Basile, S.
    Marano, L.
    Peluso, I.
    Simeone, L.
    Vitagliano, O.
    Palmieri, S.
    Rocco, S.
    Ferrara, F.
    Pane, F.
    [J]. HAEMATOLOGICA, 2017, 102 : 796 - 796
  • [4] Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
    Dharshan Sivaraj
    Michael M Green
    Yubin Kang
    Gwynn D Long
    David A Rizzieri
    Zhiguo Li
    Anderson H Garrett
    Jackie L McIntyre
    Nelson J Chao
    Cristina Gasparetto
    [J]. Blood Cancer Journal, 8
  • [5] BENDAMUSTINE : A NEW OPTION FOR RELAPSED/ REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Madonna, E.
    Marano, L.
    Pugliese, N.
    Avilia, S.
    Cerciello, G.
    Pane, F.
    Catalano, L.
    [J]. HAEMATOLOGICA, 2013, 98 : 612 - 612
  • [6] Bendamustine therapy for advanced relapsed/refractory multiple myeloma
    Shkury, Eden
    Geva, Mika
    Avigdor, Abraham
    Nevo, Lee
    Magen, Hila
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S189 - S189
  • [7] Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
    Sivaraj, Dharshan
    Green, Michael M.
    Kang, Yubin
    Long, Gwynn D.
    Rizzieri, David A.
    Li, Zhiguo
    Garrett, Anderson H.
    McIntyre, Jackie L.
    Chao, Nelson J.
    Gasparetto, Cristina
    [J]. BLOOD CANCER JOURNAL, 2018, 8
  • [8] BENDAMUSTINE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REGIONAL REAL-LIFE EXPERIENCE
    Cerchione, C.
    Catalano, L.
    Pareto, A. E.
    Basile, S.
    Marano, L.
    Peluso, I.
    Simeone, L.
    Vitagliano, O.
    Palmieri, S.
    Rocco, S.
    Ferrara, F.
    Pane, F.
    [J]. HAEMATOLOGICA, 2015, 100 : 743 - 744
  • [9] Management of Relapsed and Relapsed/Refractory Multiple Myeloma
    Laubach, Jacob P.
    Mitsiades, Constantine S.
    Mahindra, Anuj
    Luskin, Marlise R.
    Rosenblatt, Jacalyn
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Avigan, David
    Raje, Noopur
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Richardson, Paul G.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (10): : 1209 - 1216
  • [10] The Management of Relapsed and Refractory Multiple Myeloma
    Gahvari, Zhubin J.
    Callander, Natalie S.
    [J]. ONCOLOGY-NEW YORK, 2023, 37 (04): : 164 - 174
12345